Team:BIT/HP1
Entrepreneurship
Abstract
This year，the ultimate goal of our team，iGEM_BIT is to achieve the commercialization of the biomarkers detection module type (JACOB)，we need our project go into people‘s daily life，that's why we need entrepreneurship.
Starting with markets and businesses:
Through the market, we clarify the characteristics of JACOB and discard unnecessary factors.
Through the company, we optimized the design of JACOB in laboratory to make the project more consistent with the actual situation.
Market Analysis
In terms of market, our market is IVD, we has carried on the SWOT analysis to project the market, which seriously analyzes the project's strengths, weaknesses, opportunities and competition (see links). In addition, we conducted interviews with our future users and, through interviews with people of different ages, got further feedback on the project. we conducted SWOT analysis of the project，including strengths, weaknesses, opportunities and competition（Hyperlink）.In addition, we interviewed with our users of different ages,getting more information for our project.
SWOT
Strength
1. Convenience
2. Adaptability
3. High Cost/Performance Ratio
4. Inelastic to change in test conditions
Weakness
1. Technology Barrier
2. Branding Barrier
3. Strict Market Admittance Criteria
4. Distribution Barrier
Opportunity
1. Favorable national economic condition
2. Positive national policies
3. Uprising Health-consciousness
Threats
1. Well-established industries control the high-end markets with related products
2. Industrial chain is currently complete
3. Technological applications are matured
Comments
Comparing to technology equipped by clinics and hospitals, The use of adjustable aptamer and genetic modified microbes made JACOB more economical, adaptable, and stable. The integration of automated proceeding made JACOB more user-friendly and portable. JACOB does not need professional physicians reading results, behaving like glucose meter but less risky. In China it is likely to be deployed in units of household or local communities. Similarly, for United States the Food and Drug Administration classified the core mechanism of JACOB as Class I medical device (if designed to not detecting cancer biomarkers), means no premarketing control is required. It is worth noting though, Chinese in vitro diagnostic market is relatively new and have few competitors. Those few players can no longer support the concrete increasing demand for medical cares. Chinese government had ratified a great number of acts as well as guidelines and simplified documents examining and approval process to encourage innovation in the field of medical devices, which offers our team a great market environment.
Hire Us!
Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.
